81 Study F1K-MC-EVAD: Mortality by Cardiovascular Disease Severity Measures Drotrecogin Alfa N (activated) Placebo Overall Shock within 48 hrs 1214 25.1 32.0 1362 26.0 32.5 476 23.8 27.6 Yes No Cardiovascular SOFA Shock within 6 hrs Yes No Any Shock Yes No 1200 26.3 34.2 490 21.0 22.3 328 19.7 23.3 0.5 0.6 0.7 0.8 1 1.25 1.67 2 0.9 Relative Risk of Death (Point Estimate and 95% CI) 494 19.1 26.6 0 or 1 1196 27.3 32.42 to 4 1690 24.7 30.8 6314.03
{}